What is the address of SINDRIYA MEDICAL?

The registered office of SINDRIYA MEDICAL is located at Edmond Tollenaerestraat 56 box 1, 1020 Brussel.

Is SINDRIYA MEDICAL still active?

Yes. According to the CBE (17 September 2026) SINDRIYA MEDICAL is active, legal situation “Normale toestand”, started on 30 December 2021.

Is SINDRIYA MEDICAL registered on Peppol?

Yes, SINDRIYA MEDICAL is registered on the Peppol network with ID 0208:0779531986.

What is the enterprise number of SINDRIYA MEDICAL?

The enterprise number of SINDRIYA MEDICAL is BE0779531986.

When was SINDRIYA MEDICAL founded?

SINDRIYA MEDICAL was founded on 30 December 2021.

Who are the directors of SINDRIYA MEDICAL?

According to the 2025 annual accounts, the directors of SINDRIYA MEDICAL are: ISMAIL OULD-NANA.

Is SINDRIYA MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SINDRIYA MEDICAL make in 2025?

SINDRIYA MEDICAL posted a profit after taxes of € 149,319 in financial year 2025.

What is the revenue of SINDRIYA MEDICAL?

As a small company, SINDRIYA MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 217,443.

SINDRIYA MEDICAL (Private Limited) - Brussel

Dossier SINDRIYA MEDICAL, printed on 17 September 2026 from databakkes.be/en/0779531986/sindriya-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SINDRIYA MEDICAL from Brussel, company number BE0779531986, closed financial year 2025 with a result of € 149,319 after tax. For that financial year SINDRIYA MEDICAL recorded a gross margin of € 217,443 and equity of € 143,002. Compared with financial year 2024, the result moved from € 168,897 to € 149,319. The company is profitable. The buffer shrank hard: equity is 50 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.

What it is worth Shrank hard

€ 143,002

▼ 50% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 149,319

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 148,471

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 293,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 9,471

▲ 58% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 58,576

▲ 209% vs 2024

€ 38,082 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 7,142

▲ € 6,329 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 45,363

▲ 263% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 128,349 Gross margin 2022: € 128,349 First fiscal year in the series	€ 170,604 Gross margin 2023: € 170,604 ▲ 33% vs 2022 (€ 128,349) Favourable step	€ 238,200 Gross margin 2024: € 238,200 ▲ 40% vs 2023 (€ 170,604) Favourable step	€ 217,443 Gross margin 2025: € 217,443 ▼ 9% vs 2024 (€ 238,200) Unfavourable step	▼ 9%
Profit after taxes	€ 93,620 Profit after taxes 2022: € 93,620 First fiscal year in the series	€ 123,916 Profit after taxes 2023: € 123,916 ▲ 32% vs 2022 (€ 93,620) Favourable step	€ 168,897 Profit after taxes 2024: € 168,897 ▲ 36% vs 2023 (€ 123,916) Favourable step	€ 149,319 Profit after taxes 2025: € 149,319 ▼ 12% vs 2024 (€ 168,897) Unfavourable step	▼ 12%
Equity	€ 75,120 Equity 2022: € 75,120 First fiscal year in the series	€ 180,287 Equity 2023: € 180,287 ▲ 140% vs 2022 (€ 75,120) Favourable step	€ 286,683 Equity 2024: € 286,683 ▲ 59% vs 2023 (€ 180,287) Favourable step	€ 143,002 Equity 2025: € 143,002 ▼ 50% vs 2024 (€ 286,683) Unfavourable step	▼ 50%
Total debts	€ 52,170 Total debts 2022: € 52,170 First fiscal year in the series	€ 46,842 Total debts 2023: € 46,842 ▼ 10% vs 2022 (€ 52,170) Favourable step	€ 82,300 Total debts 2024: € 82,300 ▲ 76% vs 2023 (€ 46,842) Unfavourable step	€ 360,130 Total debts 2025: € 360,130 ▲ € 277,831 vs 2024 (€ 82,300) Unfavourable step	▲ € 277,831
Cash	€ 57,608 Cash 2022: € 57,608 First fiscal year in the series	€ 117,730 Cash 2023: € 117,730 ▲ 104% vs 2022 (€ 57,608) Favourable step	€ 153,465 Cash 2024: € 153,465 ▲ 30% vs 2023 (€ 117,730) Favourable step	€ 148,471 Cash 2025: € 148,471 ▼ 3% vs 2024 (€ 153,465) Unfavourable step	▼ 3%
Retained profit	€ 73,620 Retained profit 2022: € 73,620 First fiscal year in the series	€ 178,787 Retained profit 2023: € 178,787 ▲ 143% vs 2022 (€ 73,620) Favourable step	€ 285,183 Retained profit 2024: € 285,183 ▲ 60% vs 2023 (€ 178,787) Favourable step	€ 141,502 Retained profit 2025: € 141,502 ▼ 50% vs 2024 (€ 285,183) Unfavourable step	▼ 50%
Dividend	€ 20,000 Dividend 2022: € 20,000 First fiscal year in the series	€ 18,750 Dividend 2023: € 18,750 ▼ 6% vs 2022 (€ 20,000) Unchanged	€ 62,500 Dividend 2024: € 62,500 ▲ 233% vs 2023 (€ 18,750) Unchanged	€ 293,000 Dividend 2025: € 293,000 ▲ € 230,500 vs 2024 (€ 62,500) Unchanged	▲ € 230,500
Bank debt	€ 25,472 Bank debt 2022: € 25,472 First fiscal year in the series	€ 23,743 Bank debt 2023: € 23,743 ▼ 7% vs 2022 (€ 25,472) Favourable step	€ 18,987 Bank debt 2024: € 18,987 ▼ 20% vs 2023 (€ 23,743) Favourable step	€ 58,576 Bank debt 2025: € 58,576 ▲ 209% vs 2024 (€ 18,987) Unfavourable step	▲ 209%
Balance sheet total	€ 127,290 Balance sheet total 2022: € 127,290 First fiscal year in the series	€ 227,128 Balance sheet total 2023: € 227,128 ▲ 78% vs 2022 (€ 127,290) Unchanged	€ 368,983 Balance sheet total 2024: € 368,983 ▲ 62% vs 2023 (€ 227,128) Unchanged	€ 503,133 Balance sheet total 2025: € 503,133 ▲ 36% vs 2024 (€ 368,983) Unchanged	▲ 36%

Key figures of SINDRIYA MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SINDRIYA MEDICAL?

What happened at SINDRIYA MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 29, 2026 New annual accounts for financial year 2025: profit of € 149,319 (▼ 12% vs 2024). Source: NBB ↗
Jan 1, 2022 New establishment in Brussel. KBO
Dec 30, 2021 Start of the company according to the CBE. KBO

In short

From € 93,620 profit in 2022 to € 149,319 profit in 2025.

Paid € 163,208 in corporate taxes since 2022.

Best year ever: 2024, with € 168,897 profit.

Paid out € 394,250 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SINDRIYA MEDICAL? We notify you, reason included.

Follow SINDRIYA MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ISMAIL OULD-NANA

SINDRIYA MEDICAL

Behind SINDRIYA MEDICAL is ISMAIL OULD-NANA.

See the full network in the app

Directors

According to the 2025 annual accounts

ISMAIL OULD-NANA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Edmond Tollenaerestraat 56 box 1

1020 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

LES BALLETS DU GRAND MIRO

ALOHA MANAGEMENT

€ 707,579 gross margin · 2025

Pauline MESKENS

€ 21,664 gross margin · 2025

Lob Lab

€ 9,050 gross margin · 2025

MODO CREATIVE

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0779.531.986
VAT number: BE 0779.531.986
Registered office: Edmond Tollenaerestraat 56 bus 1, 1020 Brussel
Names & denominations: SINDRIYA MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 December 2021
Peppol: Active · Active since 30 Apr 2026

View on CBE Public ↗ Annual accounts (NBB) ↗